Literature DB >> 16259944

Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells.

Noritsugu Nakano1, Kazushi Urasawa, Yasushi Takagi, Takahiko Saito, Satoshi Kaneta, Susumu Ishikawa, Hideaki Higashi, Hiroyuki Tsutsui, Masanori Hatakeyama, Akira Kitabatake.   

Abstract

Immature vascular smooth muscle cells (VSMCs) proliferate responding to extrinsic mitogens and accumulate in neointima after arterial injuries. Cell proliferation is positively regulated by cyclin/cyclin-dependent kinase (CDK) complex and negatively controlled by CDK inhibitors; CKIs such as p27(kip1) and p57(kip2). In this study, embryonic rat thoracic aorta VSMCs; A10 were G0/G1 arrested by serum starvation, re-stimulated with serum, and harvested every four hours. Both CKIs co-expressed in quiescent VSMCs and rapidly diminished by stimulation. Protein level of p27(kip1) was regulated by both transcription and post-transcription, but that of p57(kip2) was mainly by post-transcription. Supplemental overexpression of p57(kip2) inhibited the activations of G1 cyclin/CDKs and subsequent hyperphosphorylations of all three retinoblastoma pocket proteins as well as G1/S transition of cell cycle. Our findings suggest that the downregulations of not only p27(kip1), but also p57(kip2) responding to mitogenic stimulation, play key roles in the cell cycle progression of VSMCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16259944     DOI: 10.1016/j.bbrc.2005.10.093

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Ca2+, calmodulin, and cyclins in vascular smooth muscle cell cycle.

Authors:  Vera V Koledova; Raouf A Khalil
Journal:  Circ Res       Date:  2006-05-26       Impact factor: 17.367

Review 2.  The COP9 signalosome and vascular function: intriguing possibilities?

Authors:  Douglas S Martin; Xuejun Wang
Journal:  Am J Cardiovasc Dis       Date:  2015-03-20

3.  A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.

Authors:  Xiaojun Liu; Yunhui Cheng; Shuo Zhang; Ying Lin; Jian Yang; Chunxiang Zhang
Journal:  Circ Res       Date:  2009-01-15       Impact factor: 17.367

Review 4.  Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.

Authors:  Dmitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.